IL1B and prostate cancer: It was reported that NLRP1 signaling is silenced to favor advanced skin tumor (20), while the expression of the NLRP1 inflammasome might promote prostate cancer through the production of proinflammatory cytokines, namely IL-1β and IL-18 (21).